BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22246008)

  • 1. Acute antidepressant and anxiolytic effects of simvastatin and its mechanisms in rats.
    Kilic FS; Ozatik Y; Kaygisiz B; Baydemir C; Erol K
    Neurosciences (Riyadh); 2012 Jan; 17(1):39-43. PubMed ID: 22246008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of single and combined gabapentin use in elevated plus maze and forced swimming tests.
    Kilic FS; Ismailoglu S; Kaygisiz B; Oner S
    Acta Neuropsychiatr; 2014 Oct; 26(5):307-14. PubMed ID: 25076169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing anxiolytic-like effects of selective serotonin reuptake inhibitors and serotonin-noradrenaline reuptake inhibitors using the elevated plus maze in mice.
    Takeuchi T; Owa T; Nishino T; Kamei C
    Methods Find Exp Clin Pharmacol; 2010 Mar; 32(2):113-21. PubMed ID: 20401348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of synergistic action following co-treatment with pramipexole and fluoxetine or sertraline in the forced swimming test in rats.
    Rogóz Z; Skuza G
    Pharmacol Rep; 2006; 58(4):493-500. PubMed ID: 16963794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression.
    Wesołowska A; Nikiforuk A
    Neuropharmacology; 2007 Apr; 52(5):1274-83. PubMed ID: 17320917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models.
    Engin E; Treit D; Dickson CT
    Neuroscience; 2009 Jun; 161(2):359-69. PubMed ID: 19321151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal tactile stimulation decreases depression-like and anxiety-like behaviors and potentiates sertraline action in young rats.
    Freitas D; Antoniazzi CT; Segat HJ; Metz VG; Vey LT; Barcelos RC; Duarte T; Duarte MM; Burger ME
    Int J Dev Neurosci; 2015 Dec; 47(Pt B):192-7. PubMed ID: 26449401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic treatment with duloxetine is necessary for an anxiolytic-like response in the mouse zero maze: the role of the serotonin transporter.
    Troelsen KB; Nielsen EØ; Mirza NR
    Psychopharmacology (Berl); 2005 Oct; 181(4):741-50. PubMed ID: 16032412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High dose of simvastatin induces hyperlocomotive and anxiolytic-like activities: The association with the up-regulation of NMDA receptor binding in the rat brain.
    Wang Q; Zengin A; Deng C; Li Y; Newell KA; Yang GY; Lu Y; Wilder-Smith EP; Zhao H; Huang XF
    Exp Neurol; 2009 Mar; 216(1):132-8. PubMed ID: 19100736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive allosteric modulation of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptors differentially modulates the behavioural effects of citalopram in mouse models of antidepressant and anxiolytic action.
    Fitzpatrick CM; Larsen M; Madsen LH; Caballero-Puntiverio M; Pickering DS; Clausen RP; Andreasen JT
    Behav Pharmacol; 2016 Sep; 27(6):549-55. PubMed ID: 27341500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity and onset of action of reboxetine and effect of combination with sertraline in an animal model of depression.
    Harkin A; Kelly JP; McNamara M; Connor TJ; Dredge K; Redmond A; Leonard BE
    Eur J Pharmacol; 1999 Jan; 364(2-3):123-32. PubMed ID: 9932714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 5-HT6 receptor agonist EMD 386088 produces antidepressant and anxiolytic effects in rats after intrahippocampal administration.
    Nikiforuk A; Kos T; Wesołowska A
    Psychopharmacology (Berl); 2011 Oct; 217(3):411-8. PubMed ID: 21499701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MCL0042: a nonpeptidic MC4 receptor antagonist and serotonin reuptake inhibitor with anxiolytic- and antidepressant-like activity.
    Chaki S; Oshida Y; Ogawa S; Funakoshi T; Shimazaki T; Okubo T; Nakazato A; Okuyama S
    Pharmacol Biochem Behav; 2005 Dec; 82(4):621-6. PubMed ID: 16337261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phytochemical screening, acute toxicity, anxiolytic and antidepressant activities of the Nelumbo nucifera fruit.
    Rajput MA; Khan RA
    Metab Brain Dis; 2017 Jun; 32(3):743-749. PubMed ID: 28144887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antidepressant- and anxiolytic-like effects following co-treatment with escitalopram and risperidone in rats.
    Kaminska K; Rogoz Z
    J Physiol Pharmacol; 2016 Jun; 67(3):471-80. PubMed ID: 27512008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonergic and noradrenergic pathways are required for the anxiolytic-like and antidepressant-like behavioral effects of repeated vagal nerve stimulation in rats.
    Furmaga H; Shah A; Frazer A
    Biol Psychiatry; 2011 Nov; 70(10):937-45. PubMed ID: 21907323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential roles of amygdaloid nuclei in the anxiolytic- and antidepressant-like effects of the V1b receptor antagonist, SSR149415, in rats.
    Salomé N; Stemmelin J; Cohen C; Griebel G
    Psychopharmacology (Berl); 2006 Aug; 187(2):237-44. PubMed ID: 16779555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose dependent effects of serotonergic agents on anxiety.
    Kolcsar M; Gáll Z; Dogaru MT
    Acta Physiol Hung; 2014 Dec; 101(4):479-87. PubMed ID: 25532957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypobaric hypoxia exposure in rats differentially alters antidepressant efficacy of the selective serotonin reuptake inhibitors fluoxetine, paroxetine, escitalopram and sertraline.
    Kanekar S; Sheth CS; Ombach HJ; Olson PR; Bogdanova OV; Petersen M; Renshaw CE; Sung YH; D'Anci KE; Renshaw PF
    Pharmacol Biochem Behav; 2018 Jul; 170():25-35. PubMed ID: 29738811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression.
    Lydiard RB; Stahl SM; Hertzman M; Harrison WM
    J Clin Psychiatry; 1997 Nov; 58(11):484-91. PubMed ID: 9413414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.